Tumour immunotherapy aims to induce or enhance tumour antigen specific immune
responses that are capable of killing tumour cells. Anogenital and oropharyngeal …

While platinum-based chemotherapy, radiation therapy and or surgery are effective in
reducing human papillomavirus (HPV) driven cancer tumours, they have some significant …

Human papilloma viruses (HPV) are the main culprit in cervical and oropharyngeal cancers.
HPV positive (+) cancers are regarded as 'oncogene addicted', displaying an absolute …

Human papillomaviruses infect keratinocytes and can lead to hyperproliferative dysplasia
and malignant transformation if not cleared by the immune system. Human papillomavirus …

High-risk human papillomavirus infection can induce cervical and other intraepithelial
neoplasia and invasive cancers. A transgenic mouse expressing keratin 14 promotor-driven …

Amongst the 20% of human cancers initiated by infection, those associated with infection
with human papillomaviruses (HPVs) are the most common, comprising 5% of the global …